Quantcast
Home / Opinion Digests / No Venue Change in Drug Antitrust Case (access required)

No Venue Change in Drug Antitrust Case (access required)

In the Federal Trade Commission’s investigation of defendant pharmaceutical company for potentially anticompetitive conduct involving its branded drug Suboxone, in which the FTC is seeking discovery of an additional 28,000 documents withheld on the ground of attorney-client privilege, the Richmond U.S. District Court denies defendant’s motion to transfer venue to a Pennsylvania federal court where ...

Leave a Reply